{"links":{"self":"https://clientapi.gcs-web.com/data/33381f6d-8eaa-46ae-8c63-71b3672717c2/filings/29286/html"},"meta":{"executionDate":"2026-04-05T01:27:48","cmsDomain":"https://bradyid.gcs-web.com"},"data":"\n\n\n\n\n\n\n\nbrc-20250221
00007465982025Q2false00007465982025-02-212025-02-21

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 21, 2025
BRADY CORPORATION
(Exact name of registrant as specified in its charter)
Commission File Number 1-14959
Wisconsin 39-0178960
(State or other jurisdiction of incorporation or organization) (IRS Employer Identification No.)
6555 West Good Hope Road
Milwaukee, Wisconsin 53223
(Address of principal executive offices and Zip Code)
(414) 358-6600
(Registrant’s Telephone Number)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered
Class A Nonvoting Common Stock, par value $0.01 per shareBRCNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐


Item 2.02RESULTS OF OPERATIONS AND FINANCIAL CONDITION

On February 21, 2025, Brady Corporation (the “Company”) issued a press release announcing its fiscal 2025 second quarter financial results. A copy of the press release is being furnished to the Securities and Exchange Commission as Exhibit 99.1 attached hereto and is incorporated herein by reference.

Item 7.01REGULATION FD DISCLOSURE

On February 21, 2025, the Company hosted a conference call related to its fiscal 2025 second quarter financial results. A copy of the slides referenced in the conference call, which is also posted on the Company’s website, is being furnished to the Securities and Exchange Commission as Exhibit 99.2 attached hereto and is incorporated herein by reference.

Item 9.01FINANCIAL STATEMENTS AND EXHIBITS

(d) Exhibits
EXHIBIT NUMBERDESCRIPTION
99.1
99.2
104Cover Page Interactive Data File (embedded within Inline XBRL document).

SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
  BRADY CORPORATION
Date: February 21, 2025
 
 /s/ ANN E. THORNTON
 Ann E. Thornton
 Chief Financial Officer, Chief Accounting Officer and Treasurer


\n\n
\n\n\nDocument

EXHIBIT 99.1


For More Information:
Investor contact: Ann Thornton 414-438-6887
Media contact: Kate Venne 414-358-5176


Brady Corporation Reports Fiscal 2025 Second Quarter Results and Raises the Low End of its Fiscal 2025 Adjusted Diluted EPS Guidance

•Sales for the quarter increased 10.6 percent. Organic sales increased 2.6 percent, acquisitions increased sales 10.2 percent and foreign currency translation decreased sales 2.2 percent.
•Diluted EPS decreased 7.8 percent to $0.83 in the second quarter of fiscal 2025 compared to $0.90 in the same quarter of the prior year. Adjusted Diluted EPS* increased 7.5 percent to $1.00 in the second quarter of fiscal 2025 compared to $0.93 in the same quarter of the prior year.
•Net cash provided by operating activities increased to $39.6 million in the second quarter of fiscal 2025 compared to $36.1 million in the second quarter of last year.
•The low end of Adjusted Diluted EPS* Guidance was raised for the full year ending July 31, 2025 from the previous range of $4.40 to $4.70 per share to the new range of $4.45 to $4.70 per share. GAAP earnings per diluted Class A Nonvoting Common share guidance for the year ending July 31, 2025 was updated to reflect facility closure and other reorganization costs to $3.99 to $4.24 per share.

MILWAUKEE (February 21, 2025) -- Brady Corporation (NYSE: BRC) (“Brady” or “Company”), a world leader in identification solutions, today reported its financial results for its fiscal 2025 second quarter ended January 31, 2025.

Quarter Ended January 31, 2025 Financial Results:
Sales for the quarter ended January 31, 2025 increased 10.6 percent, which consisted of organic sales growth of 2.6 percent, growth of 10.2 percent from acquisitions and a decline of 2.2 percent from foreign currency translation. Sales for the quarter ended January 31, 2025 were $356.7 million compared to $322.6 million in the same quarter last year. By region, sales increased 10.5 percent in the Americas & Asia and sales increased 10.7 percent in Europe & Australia, which consisted of organic sales growth of 4.3 percent in the Americas & Asia and an organic sales decline of 0.8 percent in Europe & Australia.
Income before income taxes decreased 6.8 percent to $52.0 million in the quarter ended January 31, 2025, compared to $55.8 million in the same quarter last year. Adjusted Income Before Income Taxes* in the quarter ended January 31, 2025, which was adjusted for amortization expense and facility closure and other reorganization costs of $10.3 million, was $62.4 million, an increase of 7.2 percent compared to the second quarter of last year. Adjusted Income Before Income Taxes* in the quarter ended January 31, 2024, which was adjusted for amortization expense of $2.4 million, was $58.2 million.
Net income for the quarter ended January 31, 2025 was $40.3 million compared to $43.6 million in the same quarter last year. Adjusted Net Income* in the quarter ended January 31, 2025 was $48.1 million compared to $45.4 million in the same quarter last year. Earnings per diluted Class A Nonvoting Common Share was $0.83


compared to $0.90 in the same quarter last year. Adjusted Diluted EPS* in the quarter ended January 31, 2025 was $1.00 compared to $0.93 in the same quarter last year.

Six-Month Period Ended January 31, 2025 Financial Results:
Sales for the six-month period ended January 31, 2025 increased 12.1 percent, which consisted of organic sales growth of 3.1 percent, growth of 10.0 percent from acquisitions, a decline of 0.5 percent from foreign currency translation and a decline of 0.5 percent from divestitures. Sales for the six months ended January 31, 2025 were $733.7 million compared to $654.6 million in the same period last year. By region, sales increased 10.6 percent in the Americas & Asia and sales increased 15.0 percent in Europe & Australia, which consisted of organic growth of 4.7 percent in the Americas & Asia and flat organic sales in Europe & Australia.
Income before income taxes decreased 3.8 percent to $110.8 million in the six-month period ended January 31, 2025, compared to $115.2 million in the same period last year. Adjusted Income Before Income Taxes* in the six-month period ended January 31, 2025, which was adjusted for amortization expense, facility closure and other reorganization costs and acquisition-related charges of $20.1 million, was $130.9 million, an increase of 9.2 percent compared to the same period last year. Adjusted Income Before Income Taxes* in the six-month period ended January 31, 2024, which was adjusted for amortization expense of $4.7 million, was $119.9 million.
Net income in the six-month period ended January 31, 2025 was $87.1 million compared to $90.9 million in the same period last year. Adjusted Net Income* in the six-month period ended January 31, 2025 was $102.3 million compared to $94.5 million in the same period last year. Earnings per diluted Class A Nonvoting Common Share was $1.81 compared to $1.86 in the same period last year. Adjusted Diluted EPS* in the six-month period ended January 31, 2025 was $2.12 compared to $1.94 in the same period last year.

Commentary:
“Our investments in research and development continue to drive the introduction of new products such as our i7500 high-speed printer, which was launched this quarter. It creates value for our customers by using our LabelSenseTM technology to enable rapid material changeover with zero waste,” said Brady’s President and Chief Executive Officer, Russell R. Shaller. “On a regional basis, the Americas and Asia region performed well with another quarter of strong organic sales growth and improvement in segment profit. Brady has a clear roadmap defined using our R&D to create innovative products while continuing to improve our operational efficiency.”
“We generated adjusted EPS of $1.00 this quarter, which represented 7.5 percent growth compared to the second quarter of last year,” said Brady’s Chief Financial Officer, Ann Thornton. “This performance was driven by organic sales growth and a continued focus on long-term operational efficiency opportunities. Our balance sheet is strong and our net cash position increased to $50.8 million this quarter, which provides us with the flexibility to fully fund our organic and inorganic opportunities, and return funds to our shareholders through dividends and share buybacks. We believe we are positioned to continue to deliver improved long-term financial results to our shareholders.”

Fiscal 2025 Guidance:
The Company raised the low end of its Adjusted Diluted EPS* guidance for the year ending July 31, 2025 from $4.40 to $4.70 per share to $4.45 to $4.70 per share. The Company’s GAAP earnings per diluted Class A


Nonvoting Common Share guidance for the year ending July 31, 2025 was updated for facility closure and other reorganization costs incurred to date to $3.99 to $4.24 per share, from $4.02 to $4.32 per share.
The assumptions included in fiscal 2025 guidance include a full-year income tax rate of approximately 21 percent, depreciation and amortization expense of approximately $40 million, and capital expenditures of approximately $35 million. Fiscal 2025 guidance is based upon foreign currency exchange rates as of January 31, 2025 and assumes economic growth.

A webcast regarding Brady’s fiscal 2025 second quarter financial results will be available at www.bradycorp.com/investors beginning at 9:30 a.m. central time today.

Brady Corporation is an international manufacturer and marketer of complete solutions that identify and protect people, products and places. Brady’s products help customers increase safety, security, productivity and performance and include high-performance labels, signs, safety devices, printing systems and software. Founded in 1914, the Company has a diverse customer base in electronics, telecommunications, manufacturing, electrical, construction, medical, aerospace and a variety of other industries. Brady is headquartered in Milwaukee, Wisconsin and as of July 31, 2024, employed approximately 5,700 people in its worldwide businesses. Brady’s fiscal 2024 sales were approximately $1.34 billion. Brady stock trades on the New York Stock Exchange under the symbol BRC. More information is available on the Internet at www.bradyid.com.

* Adjusted Income Before Income Taxes, Adjusted Net Income, and Adjusted Diluted EPS are non-GAAP measures. See appendix for more information on these measures, including reconciliations to the most directly comparable GAAP measures.




###

In this news release, statements that are not reported financial results or other historic information are “forward-looking statements.” These forward-looking statements relate to, among other things, the Company's future financial position, business strategy, targets, projected sales, costs, earnings, capital expenditures, debt levels and cash flows, and plans and objectives of management for future operations.

The use of words such as “may,” “will,” “expect,” “intend,” “estimate,” “anticipate,” “believe,” “should,” “project,” “plan” or similar terminology are generally intended to identify forward-looking statements. These forward-looking statements by their nature address matters that are, to different degrees, uncertain and are subject to risks, assumptions, and other factors, some of which are beyond Brady’s control, that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. For Brady, uncertainties arise from: increased cost of raw materials and labor as well as material shortages and supply chain disruptions; decreased demand for our products; our ability to compete effectively or to successfully execute our strategy; our ability to develop technologically advanced products that meet customer demands; Brady’s ability to identify, integrate and grow acquired companies, and to manage contingent liabilities from divested businesses; difficulties in protecting our websites, networks, and systems against security breaches; risks associated with the loss of key employees; extensive regulations by U.S. and non-U.S. governmental and self-regulatory entities; global climate change and environmental regulations; litigation, including product liability claims; foreign currency fluctuations; changes in tax legislation and tax rates; potential write-offs of goodwill and other intangible assets; differing interests of voting and non-voting shareholders and changes in the regulatory and business environment around dual-class voting structures; numerous other matters of national, regional and global scale, including major public health crises and government responses thereto and those of a political, economic, business, competitive, and regulatory nature contained from time to time in Brady’s U.S. Securities and Exchange Commission filings, including, but not limited to, those factors listed in the “Risk Factors” section within Item 1A of Part I of Brady’s Form 10-K for the year ended July 31, 2024.

These uncertainties may cause Brady's actual future results to be materially different than those expressed in its forward-looking statements. Brady does not undertake to update its forward-looking statements except as required by law.


BRADY CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF INCOME
(Unaudited; Dollars in thousands, except per share data)

Three months ended January 31,Six months ended January 31,
 2025202420252024
Net sales$356,675 $322,624 $733,740 $654,607 
Cost of goods sold180,832 160,541 368,208 320,805 
Gross margin175,843 162,083 365,532 333,802 
Operating expenses:
Research and development18,723 16,832 37,644 32,534 
Selling, general and administrative105,886 91,325 217,732 187,612 
Total operating expenses124,609 108,157 255,376 220,146 
Operating income 51,234 53,926 110,156 113,656 
Other income (expense):
Investment and other income2,125 2,684 3,359 3,122 
Interest expense(1,312)(790)(2,668)(1,556)
Income before income taxes52,047 55,820 110,847 115,222 
Income tax expense11,713 12,192 23,730 24,353 
Net income$40,334 $43,628 $87,117 $90,869 
Net income per Class A Nonvoting Common Share:
Basic$0.84 $0.90 $1.82 $1.88 
Diluted$0.83 $0.90 $1.81 $1.86 
Net income per Class B Voting Common Share:
Basic$0.84 $0.90 $1.81 $1.86 
Diluted$0.83 $0.90 $1.79 $1.85 
Weighted average common shares outstanding:
Basic47,851 48,374 47,792 48,440 
Diluted48,306 48,725 48,261 48,768 



BRADY CORPORATION AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(Dollars in thousands)

 January 31, 2025July 31, 2024
(Unaudited)
ASSETS
Current assets:
Cash and cash equivalents$138,452 $250,118 
Accounts receivable, net of allowance for credit losses of $9,227 and $6,749, respectively201,973 185,486 
Inventories181,810 152,729 
Prepaid expenses and other current assets14,080 11,382 
Total current assets536,315 599,715 
Property, plant and equipment—net199,075 195,758 
Goodwill661,288 589,611 
Other intangible assets108,456 51,839 
Deferred income taxes16,587 15,596 
Operating lease assets42,135 38,504 
Other assets24,844 24,546 
Total$1,588,700 $1,515,569 
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable$90,968 $84,691 
Accrued compensation and benefits69,551 77,954 
Taxes, other than income taxes18,794 14,061 
Accrued income taxes4,416 7,424 
Current operating lease liabilities14,922 13,382 
Other current liabilities83,699 67,170 
Total current liabilities282,350 264,682 
Long-term debt87,687 90,935 
Long-term operating lease liabilities27,546 25,342 
Other liabilities70,649 67,952 
Total liabilities468,232 448,911 
Stockholders’ equity:
Common stock:
Class A nonvoting common stock—Issued 51,261,487 shares, and outstanding 44,241,601 and 44,042,462 shares, respectively513 513 
Class B voting common stock—Issued and outstanding, 3,538,628 shares35 35 
Additional paid-in capital356,531 353,654 
Retained earnings1,238,275 1,174,025 
Treasury stock—7,019,886 and 7,219,025 shares, respectively, of Class A nonvoting common stock, at cost(343,059)(351,947)
Accumulated other comprehensive loss(131,827)(109,622)
Total stockholders’ equity1,120,468 1,066,658 
Total$1,588,700 $1,515,569 



BRADY CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited; Dollars in thousands)

Six months ended January 31,
20252024
Operating activities:
Net income$87,117 $90,869 
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization20,096 15,008 
Stock-based compensation expense7,993 5,263 
Deferred income taxes(3,076)(3,640)
Other231 947 
Changes in operating assets and liabilities:
Accounts receivable6,605 (5,030)
Inventories(8,384)10,078 
Prepaid expenses and other assets(2,571)(1,187)
Accounts payable and accrued liabilities(41,650)(9,754)
Income taxes(3,361)(4,203)
Net cash provided by operating activities63,000 98,351 
Investing activities:
Purchases of property, plant and equipment(14,423)(60,832)
Acquisition of businesses, net of cash acquired(137,348)— 
Other53 — 
Net cash used in investing activities(151,718)(60,832)
Financing activities:
Payment of dividends(22,867)(22,694)
Proceeds from exercise of stock options5,712 5,366 
Payments for employee taxes withheld from stock-based awards(2,130)(2,362)
Purchase of treasury stock— (21,797)
Proceeds from borrowing on credit agreement159,373 69,145 
Repayment of borrowing on credit agreement(162,621)(70,771)
Other190 149 
Net cash used in financing activities(22,343)(42,964)
Effect of exchange rate changes on cash and cash equivalents(605)(2,227)
Net decrease in cash and cash equivalents(111,666)(7,672)
Cash and cash equivalents, beginning of period250,118 151,532 
Cash and cash equivalents, end of period$138,452 $143,860 



BRADY CORPORATION AND SUBSIDIARIES
SEGMENT INFORMATION
(Unaudited; Dollars in thousands)

Three months ended January 31,Six months ended January 31,
2025202420252024
NET SALES
Americas & Asia$233,846 $211,643 $479,274 $433,269 
Europe & Australia122,829 110,981 254,466 221,338 
Total$356,675 $322,624 $733,740 $654,607 
SALES INFORMATION
Americas & Asia
Organic4.3 %1.2 %4.7 %2.3 %
Acquisitions7.6 %— %7.5 %— %
Currency(1.4)%0.1 %(0.8)%— %
Divestiture— %(5.1)%(0.8)%(3.5)%
Total10.5 %(3.8)%10.6 %(1.2)%
Europe & Australia
Organic(0.8)%2.5 %— %2.0 %
Acquisitions15.1 %— %15.1 %— %
Currency(3.6)%2.0 %(0.1)%3.3 %
Total10.7 %4.5 %15.0 %5.3 %
Total Company
Organic2.6 %1.6 %3.1 %2.2 %
Acquisitions10.2 %— %10.0 %— %
Currency(2.2)%0.8 %(0.5)%1.1 %
Divestiture— %(3.5)%(0.5)%(2.4)%
Total10.6 %(1.1)%12.1 %0.9 %
SEGMENT PROFIT
Americas & Asia$45,986 $43,895 $100,886 $93,792 
Europe & Australia11,378 15,054 24,492 31,798 
Total segment profit$57,364 $58,949 $125,378 $125,590 
SEGMENT PROFIT AS A PERCENT OF NET SALES
Americas & Asia19.7 %20.7 %21.0 %21.6 %
Europe & Australia9.3 %13.6 %9.6 %14.4 %
Total16.1 %18.3 %17.1 %19.2 %
Three months ended January 31,Six months ended January 31,
2025202420252024
Total segment profit$57,364 $58,949 $125,378 $125,590 
Unallocated amounts:
Administrative costs(6,130)(5,023)(15,222)(11,934)
Investment and other income2,125 2,684 3,359 3,122 
Interest expense(1,312)(790)(2,668)(1,556)
Income before income taxes$52,047 $55,820 $110,847 $115,222 



GAAP to NON-GAAP MEASURES
(Unaudited; Dollars in Thousands, Except Per Share Amounts)
In accordance with the U.S. Securities and Exchange Commission’s Regulation G, the following provides definitions of the non-GAAP measures used in the earnings release and the reconciliation to the most closely related GAAP measure.
Adjusted Income Before Income Taxes:
Brady is presenting the non-GAAP measure, "Adjusted Income Before Income Taxes." This is not a calculation based upon GAAP. The amounts included in this non-GAAP measure are derived from amounts included in the Consolidated Financial Statements and supporting footnote disclosures. We do not view these items to be part of our ongoing results. We believe this profit measure provides an important perspective of underlying business trends and results and provides a more comparable measure from year to year. The table below provides a reconciliation of the GAAP measure of Income before income taxes to the non-GAAP measure of Adjusted Income Before Income Taxes:
Three months ended January 31,Six months ended January 31,
2025202420252024
Income before income taxes (GAAP measure)$52,047 $55,820 $110,847 $115,222 
Amortization expense4,671 2,364 9,384 4,719 
Facility closure and other reorganization costs5,654 — 5,654 — 
Non-recurring acquisition-related costs and other expenses— — 5,059 — 
Adjusted Income Before Income Taxes (non-GAAP measure)$62,372 $58,184 $130,944 $119,941 


Adjusted Income Tax Expense:
Brady is presenting the non-GAAP measure, "Adjusted Income Tax Expense." This is not a calculation based upon GAAP. The amounts included in this non-GAAP measure are derived from amounts included in the Consolidated Financial Statements and supporting footnote disclosures. We do not view these items to be part of our ongoing results. We believe this measure provides an important perspective of underlying business trends and results and provides a more comparable measure from year to year. The table below provides a reconciliation of the GAAP measure of Income tax expense to the non-GAAP measure of Adjusted Income Tax Expense:
Three months ended January 31,Six months ended January 31,
2025202420252024
Income tax expense (GAAP measure)$11,713 $12,192 $23,730 $24,353 
Amortization expense1,125 548 2,258 1,094 
Facility closure and other reorganization costs1,413 — 1,413 — 
Non-recurring acquisition-related costs and other expenses— — 1,265 — 
Adjusted Income Tax Expense (non-GAAP measure)$14,251 $12,740 $28,666 $25,447 




Adjusted Net Income:
Brady is presenting the non-GAAP measure, "Adjusted Net Income." This is not a calculation based upon GAAP. The amounts included in this non-GAAP measure are derived from amounts included in the Consolidated Financial Statements and supporting footnote disclosures. We do not view these items to be part of our ongoing results. We believe this measure provides an important perspective of underlying business trends and results and provides a more comparable measure from year to year. The table below provides a reconciliation of the GAAP measure of Net income to the non-GAAP measure of Adjusted Net Income:
Three months ended January 31,Six months ended January 31,
2025202420252024
Net income (GAAP measure)$40,334 $43,628 $87,117 $90,869 
Amortization expense3,546 1,816 7,126 3,625 
Facility closure and other reorganization costs4,241 — 4,241 — 
Non-recurring acquisition-related costs and other expenses— — 3,794 — 
Adjusted Net Income (non-GAAP measure)$48,121 $45,444 $102,278 $94,494 


Adjusted Diluted EPS:
Brady is presenting the non-GAAP measure, "Adjusted Diluted EPS." This is not a calculation based upon GAAP. The amounts included in this non-GAAP measure are derived from amounts included in the Consolidated Financial Statements. We do not view these items to be part of our ongoing results. We believe this measure provides an important perspective of underlying business trends and results and provides a more comparable measure from year to year. The table below provides a reconciliation of the GAAP measure of Net income per Class A Nonvoting Common Share to the non-GAAP measure of Adjusted Diluted EPS (Note that certain amounts will not foot due to rounding):
Three months ended January 31,Six months ended January 31,
2025202420252024
Net income per Class A Nonvoting Common Share (GAAP measure)$0.83 $0.90 $1.81 $1.86 
Amortization expense0.07 0.04 0.15 0.07 
Facility closure and other reorganization costs0.09 — 0.09 — 
Non-recurring acquisition-related costs and other expenses— — 0.08 — 
Adjusted Diluted EPS (non-GAAP measure)$1.00 $0.93 $2.12 $1.94 


Adjusted Diluted EPS Guidance:
Fiscal 2025 Expectations
LowHigh
Earnings per Class A Nonvoting Common Share (GAAP measure)$3.99 $4.24 
Amortization expense0.29 0.29 
Facility closure and other reorganization costs0.09 0.09 
Non-recurring acquisition-related costs and other expenses0.08 0.08 
Adjusted Diluted EPS (non-GAAP measure)$4.45 $4.70 

\n
\n\nf25q2conferencecallprese\n\n\n
\n
\n
\n\n
F’25 Q2 Financial Results Brady Corporation February 21, 2025
\n

\n

 
\n
\n\n
\n\n
Forward-Looking Statements In this news release, statements that are not reported financial results or other historic information are “forward-looking statements.” These forward-looking statements relate to, among other things, the Company's future financial position, business strategy, targets, projected sales, costs, income, capital expenditures, debt levels and cash flows, and plans and objectives of management for future operations. The use of words such as “may,” “will,” “expect,” “intend,” “estimate,” “anticipate,” “believe,” “should,” “project,” “plan” or similar terminology are generally intended to identify forward-looking statements. These forward-looking statements by their nature address matters that are, to different degrees, uncertain and are subject to risks, assumptions, and other factors, some of which are beyond Brady’s control, that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. For Brady, uncertainties arise from: increased cost of raw materials and labor as well as raw material shortages and supply chain disruptions; decreased demand for our products; our ability to compete effectively or to successfully execute our strategy; our ability to develop technologically advanced products that meet customer demands; Brady’s ability to identify, integrate, and grow acquired companies, and to manage contingent liabilities from divested businesses; difficulties in protecting our websites, networks and systems against security breaches; risks associated with the loss of key employees; extensive regulations by U.S. and non-U.S. governmental and self-regulatory entities; global climate change and environmental regulations; litigation, including product liability claims; foreign currency fluctuations; potential write-offs of goodwill and other intangible assets; differing interests of voting and non-voting shareholders and changes in the regulatory and business environment around dual-class voting structures; changes in tax legislation and tax rates; numerous other matters of national, regional and global scale, including major public health crises and government responses thereto and those of a political, economic, business, competitive, and regulatory nature contained from time to time in Brady’s U.S. Securities and Exchange Commission filings, including, but not limited to, those factors listed in the “Risk Factors” section within Item 1A of Part I of Brady’s Form 10-K for the year ended July 31, 2024. These uncertainties may cause Brady's actual future results to be materially different than those expressed in its forward- looking statements. Brady does not undertake to update its forward-looking statements except as required by law. 2
\n

\n

 
\n
\n\n
\n\n
Q2 F’25 Highlights 3 * Adjusted Diluted Earnings per Share is a non-GAAP measure. See appendix. Organic sales growth of 2.6%. Americas & Asia organic sales growth of 4.3%. Europe & Australia organic sales decline of 0.8%. Acquisition growth of 10.2%. Sales Growth GPM of 49.3% compared to 50.2% in Q2 of F’24. Gross profit includes facility closure and other reorganization costs in Q2 F’25. Gross Profit Margin GAAP EPS of $0.83 compared to $0.90 in Q2 of last year. Adjusted Diluted Earnings per Share* increased 7.5% to $1.00 in Q2 of F’25 compared to $0.93 in Q2 of F’24. Growth in Adjusted Diluted Earnings per Share* Paid dividends of $11.5M. In a net cash position of $50.8M at January 31, 2025. Returning Capital to our Shareholders
\n

\n

 
\n
\n\n
\n\n
Sales Overview 4 Q2 F’25 SALES: Total sales increased 10.6%. Organic sales increased 2.6%. • Americas & Asia – Organic sales increased 4.3%. • Europe & Australia – Organic sales declined 0.8%. Foreign currency translation decreased sales 2.2%. Acquisitions increased sales 10.2%. $321 $318 $339 $324 $323 $326 $337 $346 $332 $323 $343 $343 $377 $357 $225 $250 $275 $300 $325 $350 $375 Q1 F'22 7.0% Q2 F'22 13.1% Q3 F'22 9.0% Q4 F'22 9.0% Q1 F'23 6.9% Q2 F'23 6.3% Q3 F'23 1.9% Q4 F'23 6.9% Q1 F'24 2.7% Q2 F'24 1.6% Q3 F'24 4.5% Q4 F'24 1.6% Q1 F'25 3.6% Q2 F'25 2.6%Organic Growth SALES (millions of USD) Q2 F’25 SALES COMMENTARY: Organic sales grew 3.4% in the Americas with growth in most major product lines. Asia organic sales grew 11.3% with growth across the region offsetting a decline in organic sales in China. Organic sales were flat in Europe with growth in Eastern Europe offsetting a decline in Western Europe. Australia organic sales declined 6.4%.
\n

\n

 
\n
\n\n
\n\n
Gross Profit Margin 5 $155 $149 $164 $163 $155 $156 $170 $176 $172 $162 $177 $177 $190 $176 48.2% 47.0% 48.4% 50.4% 48.1% 48.0% 50.3% 50.8% 51.7% 50.2% 51.6% 51.6% 50.3% 49.3% 38% 40% 42% 44% 46% 48% 50% 52% $100 $125 $150 $175 $200 Q1 F'22 Q2 F'22 Q3 F'22 Q4 F'22 Q1 F'23 Q2 F'23 Q3 F'23 Q4 F'23 Q1 F'24 Q2 F'24 Q3 F'24 Q4 F'24 Q1 F'25 Q2 F'25 GROSS PROFIT & GPM% (millions of USD) Q2 F’25 – GROSS PROFIT MARGIN: Gross profit margin of 49.3% compared to 50.2% in Q2 of F’24. The impact of facility closures and other reorganization costs reduced gross profit margin by approximately 70 basis points in Q2 of F’25.
\n

\n

 
\n
\n\n
\n\n
SG&A Expense 6 Q2 F’25 – SG&A EXPENSE: SG&A expense increased as a percent of sales when compared to Q2 last year primarily due to increased amortization and facility closure and other reorganization costs. Amortization expense was $4.7M in Q2 of F’25 and $2.4M in Q2 of F’24, and facility closure and other reorganization costs were $3.4M in Q2 of F’25. We continue to drive efficiencies in SG&A expenses while investing in sales-generating resources. $97 $93 $96 $95 $90 $92 $91 $97 $96 $91 $96 $93 $112 $106 30.1% 29.1% 28.4% 29.2% 27.9% 28.3% 27.0% 28.2% 29.0% 28.3% 27.9% 27.2% 29.7% 29.7% 10% 15% 20% 25% 30% 35% $60 $70 $80 $90 $100 $110 $120 Q1 F'22 Q2 F'22 Q3 F'22 Q4 F'22 Q1 F'23 Q2 F'23 Q3 F'23 Q4 F'23 Q1 F'24 Q2 F'24 Q3 F'24 Q4 F'24 Q1 F'25 Q2 F'25 SG&A EXPENSE AND SG&A EXPENSE AS A % OF SALES (millions of USD)
\n

\n

 
\n
\n\n
\n\n
R&D Expense 7 Q2 F’25 – R&D EXPENSE: We are focused on ensuring that our R&D spend is both efficient and effective. We remain committed to our investments in R&D in order to drive profitable long-term sales growth through our new product roadmap. $13.9 $14.0 $14.9 $15.8 $13.9 $15.4 $15.7 $16.3 $15.7 $16.8 $17.7 $17.5 $18.9 $18.7 4.3% 4.4% 4.4% 4.9% 4.3% 4.7% 4.7% 4.7% 4.7% 5.2% 5.1% 5.1% 5.0% 5.2% 1.5% 2.5% 3.5% 4.5% 5.5% $8.0 $10.0 $12.0 $14.0 $16.0 $18.0 $20.0 Q1 F'22 Q2 F'22 Q3 F'22 Q4 F'22 Q1 F'23 Q2 F'23 Q3 F'23 Q4 F'23 Q1 F'24 Q2 F'24 Q3 F'24 Q4 F'24 Q1 F'25 Q2 F'25 R&D EXPENSE AND R&D EXPENSE AS A % OF SALES (millions of USD)
\n

\n

 
\n
\n\n
\n\n
Income Before Income Taxes 8 $44.7 $42.0 $51.3 $54.0 $50.3 $48.5 $63.0 $63.8 $59.4 $55.8 $64.4 $68.2 $58.8 $52.0 $10 $20 $30 $40 $50 $60 $70 Q1 F'22 5.8% Q2 F'22 6.7% Q3 F'22 7.3% Q4 F'22 29.7% Q1 F'23 12.6% Q2 F'23 15.4% Q3 F'23 23.0% Q4 F'23 18.2% Q1 F'24 18.0% Q2 F'24 15.1% Q3 F'24 2.2% Q4 F'24 6.9% Q1 F'25 (1.0%) Q2 F'25 (6.8%) * Adjusted Income Before Income Taxes is a non-GAAP measure. See appendix. (millions of USD)INCOME BEFORE INCOME TAXES (GAAP) Q2 F’25 – INCOME BEFORE INCOME TAXES: GAAP Income before income taxes was down 6.8% to $52.0M in Q2 of F’25 compared to $55.8M in Q2 of F’24. Excluding adjusted* items from both periods, income before income taxes was up 7.2% to $62.4M in Q2 of F’25 compared to $58.2M in Q2 of F’24. Year-on-Year Growth (Decline)
\n

\n

 
\n
\n\n
\n\n
Net Income & Diluted EPS 9 Q2 F’25 – NET INCOME & DILUTED EPS: GAAP Net Income was $40.3M in Q2 of F’25 compared to $43.6M in Q2 of F’24 (a decrease of 7.6%). • Adjusted Net Income* was $48.1M in Q2 of F’25 compared to $45.4M in Q2 of F’24 (an increase of 5.9%). GAAP Diluted EPS was $0.83 in Q2 of F’25 compared to $0.90 in Q2 of F’24. • Adjusted Diluted EPS* was $1.00 in Q2 of F’25 compared to $0.93 in Q2 of F’24 (an increase of 7.5%). * Adjusted Net Income and Adjusted Diluted EPS are non-GAAP measures. See appendix. $35.0 $33.8 $40.1 $41.1 $39.4 $38.0 $48.1 $49.4 $47.2 $43.6 $50.9 $55.5 $46.8 $40.3 $20 $30 $40 $50 $60 Q1 F'22 Q2 F'22 Q3 F'22 Q4 F'22 Q1 F'23 Q2 F'23 Q3 F'23 Q4 F'23 Q1 F'24 Q2 F'24 Q3 F'24 Q4 F'24 Q1 F'25 Q2 F'25 NET INCOME (GAAP) (millions of USD) $0.67 $0.65 $0.78 $0.81 $0.79 $0.76 $0.96 $1.00 $0.97 $0.90 $1.05 $1.15 $0.97 $0.83 $0.20 $0.40 $0.60 $0.80 $1.00 $1.20 Q1 F'22 Q2 F'22 Q3 F'22 Q4 F'22 Q1 F'23 Q2 F'23 Q3 F'23 Q4 F'23 Q1 F'24 Q2 F'24 Q3 F'24 Q4 F'24 Q1 F'25 Q2 F'25 DILUTED EPS (GAAP)
\n

\n

 
\n
\n\n
\n\n
Cash Generation 10 CASH FLOW FROM OPERATING ACTIVITIES $27.5 ($3.2) $40.9 $53.2 $28.0 $29.4 $72.5 $79.3 $62.3 $36.1 $72.7 $84.0 $23.4 $39.6 -$5 $20 $45 $70 $95 Q1 F'22 78% Q2 F'22 (9%) Q3 F'22 102% Q4 F'22 130% Q1 F'23 71% Q2 F'23 77% Q3 F'23 151% Q4 F'23 161% Q1 F'24 132% Q2 F'24 83% Q3 F'24 143% Q4 F'24 151% Q1 F'25 50% Q2 F'25 98%% of Net Income CASH FLOWS IN Q2 OF F’25: Overview: Cash flow from operating activities was $39.6M in Q2 of F’25 vs. $36.1M in Q2 of F’24. Free cash flow* was $32.5M in Q2 of F’25 compared to ($13.5M) in Q2 of F’24. Free cash flow was negative in Q2 of F’24 due to the purchase of a previously leased facility. We returned $11.5M to our shareholders in the form of dividends. * Free cash flow is calculated as Net Cash Provided by Operating Activities less Capital Expenditures. (millions of USD) (millions of USD) 3 Mos. Ended Jan. 31, 2025 3 Mos. Ended Jan. 31, 2024 6 Mos. Ended Jan. 31, 2025 6 Mos. Ended Jan. 31, 2024 Cash Balance - Beginning of Period 145.7$ 175.4$ 250.1$ 151.5$ Cash Flow from Operating Activities 39.6 36.1 63.0 98.4 Capital Expenditures (7.1) (49.6) (14.4) (60.8) Dividends (11.5) (11.4) (22.9) (22.7) Share Repurchases - (7.7) - (21.8) Business Acquisitions - - (137.3) - Debt Borrowings / (Repayments) (29.0) (4.2) (3.2) (1.6) Effect of Exchange Rates on Cash (2.4) 3.5 (0.6) (2.2) Other 3.2 1.8 3.8 3.1 Cash Balance - End of Period 138.5$ 143.9$ 138.5$ 143.9$
\n

\n

 
\n
\n\n
\n\n
Net Cash 11 STRONG BALANCE SHEET: January 31, 2025 cash = $138.5M. January 31, 2025 debt = $87.7M. Balance sheet provides flexibility for future organic and inorganic investments. $91 $64 $26 $19 $15 $31 $84 $102 $123 $96 $97 $159 $29 $51 $0 $50 $100 $150 $200 $250 $300 $350 Q1 F'22 Q2 F'22 Q3 F'22 Q4 F'22 Q1 F'23 Q2 F'23 Q3 F'23 Q4 F'23 Q1 F'24 Q2 F'24 Q3 F'24 Q4 F'24 Q1 F'25 Q2 F'25 NET CASH (millions of USD)
\n

\n

 
\n
\n\n
\n\n
F’25 Diluted EPS Guidance GAAP Diluted EPS $3.99 to $4.24 F’25 Adjusted Diluted EPS* $4.45 to $4.70 Guidance Assumptions: Organic sales growth in the low-single digit percentages. Full-year income tax rate of approximately 21%. Foreign currency exchange rates as of January 31, 2025. Depreciation and amortization expense of approximately $40M. Capital expenditures of approximately $35M. Adjusted Diluted EPS guidance represents a range of 5.5% growth to 11.4% growth vs. F’24. 12 * Adjusted Diluted EPS is a non-GAAP measure. See appendix.
\n

\n

 
\n
\n\n
\n\n
Americas & Asia 13 • Revenues increased 10.5% in Q2 of F’25: • Organic growth = + 4.3%. • Fx decrease = (1.4%). • Acquisition = + 7.6%. • Organic sales grew 3.4% in the Americas with growth in most major product lines. • Organic sales grew 11.3% in Asia; growth throughout the region more than offset an organic sales decline in China. • Growth in segment profit due to organic sales growth in higher gross margin product lines, which was partially offset by increased amortization from acquisitions and facility closure and other reorganization costs. Excluding these increased costs, segment profit increased 12.0%. Q2 F’25 SUMMARY:Q2 F’25 vs. Q2 F’24 (millions of USD) $218 $220 $223 $227 $222 $212 $225 $228 $245 $234 19% 18% 22% 22% 23% 21% 22% 23% 22% 20% 0% 5% 10% 15% 20% 25% $100 $150 $200 $250 $300 Q1 F'23 4.0% (1.4%) - Q2 F'23 6.9% (1.0%) - Q3 F'23 1.2% (0.8%) (0.3%) Q4 F'23 5.6% (0.2%) (1.0%) Q1 F'24 3.3% - (1.9%) Q2 F'24 1.2% 0.1% (5.1%) Q3 F'24 4.5% (0.1%) (3.5%) Q4 F'24 3.4% (0.8%) (2.2%) Q1 F'25 5.1% (0.2%) 5.8% Q2 F'25 4.3% (1.4%) 7.6% SALES & SEGMENT PROFIT % (millions of USD) Q2 F’25 Q2 F’24 Change Sales $ 233.8 $ 211.6 10.5% Segment Profit 46.0 43.9 + 4.8% Segment Profit % 19.7% 20.7% - 100 bps • Organic sales growth of approximately 4% in F’25. • Growth in segment profit excluding amortization and facility closure and other reorganization costs. OUTLOOK: Organic For. Curr. Acq. & Div.
\n

\n

 
\n
\n\n
\n\n
Europe & Australia 14 • Revenues increased 10.7% in Q2 of F’25: • Organic decline = (0.8%). • Fx decrease = (3.6%). • Acquisition = 15.1% • Organic sales were flat in Europe and declined 6.4% in Australia. Growth in product ID and wire ID was offset by a decline in safety and facility ID. • Segment profit decreased due to increased amortization and facility closure and other reorganization costs. Excluding these increased costs, segment profit increased 3.9%. Q2 F’25 SUMMARY:Q2 F’25 vs. Q2 F’24 (millions of USD) $104 $106 $114 $118 $110 $111 $119 $115 $132 $123 16% 13% 15% 16% 15% 14% 16% 17% 10% 9% 0% 5% 10% 15% $50 $75 $100 $125 $150 Q1 F'23 12.8% (17.0%) - Q2 F'23 5.2% (8.9%) - Q3 F'23 3.4% (4.8%) - Q4 F'23 9.5% 2.0% - Q1 F'24 1.4% 4.6% - Q2 F'24 2.5% 2.0% - Q3 F'24 4.4% (0.6%) - Q4 F'24 (1.8%) (1.2%) - Q1 F'25 0.7% 3.6% 15.0% Q2 F'25 (0.8%) (3.6%) 15.1% SALES & SEGMENT PROFIT % Q2 F’25 Q2 F’24 Change Sales $ 122.8 $ 111.0 10.7% Segment Profit 11.4 15.1 (24.4%) Segment Profit % 9.3% 13.6% - 430 bps Organic For. Curr. Acquisitions • Organic sales growth in the low-single digit percentages in F’25. • Growth in segment profit excluding amortization and facility closure and other reorganization costs. OUTLOOK: (millions of USD)
\n

\n

 
\n
\n\n
\n\n
Investor Relations Brady Contact: Ann Thornton Investor Relations 414-438-6887 Ann_Thornton@bradycorp.com See our website at www.bradycorp.com/investors 15
\n

\n

 
\n
\n\n
\n\n
Appendix GAAP to Non-GAAP Reconciliations
\n

\n

 
\n
\n\n
\n\n
Non-GAAP Reconciliations 17 2025 2024 2025 2024 52,047$ 55,820$ 110,847$ 115,222$ Amortization expense 4,671 2,364 9,384 4,719 Facility closure and other reorganization costs 5,654 - 5,654 - Non-recurring acquisition-related costs and other expenses - - 5,059 - 62,372$ 58,184$ 130,944$ 119,941$ 2025 2024 2025 2024 11,713$ 12,192$ 23,730$ 24,353$ Amortization expense 1,125 548 2,258 1,094 Facility closure and other reorganization costs 1,413 - 1,413 - Non-recurring acquisition-related costs and other expenses - - 1,265 - 14,251$ 12,740$ 28,666$ 25,447$ GAAP to NON-GAAP MEASURES (Unaudited; Dollars in Thousands, Except Per Share Amounts) In accordance with the U.S. Securities and Exchange Commission’s Regulation G, the following provides definitions of the non-GAAP measures used in the earnings release and the reconciliation to the most closely related GAAP measure. Three months ended January 31, Three months ended January 31, Adjusted Income Tax Expense (non-GAAP measure) Income before income taxes Adjusted Income Before Income Taxes (non-GAAP measure) Brady is presenting the non-GAAP measure, "Adjusted Income Tax Expense." This is not a calculation based upon GAAP. The amounts included in this non-GAAP measure are derived from amounts included in the Consolidated Financial Statements and supporting footnote disclosures. We do not view these items to be part of our ongoing results. We believe this measure provides an important perspective of underlying business trends and results and provides a more comparable measure from year to year. The table below provides a reconciliation of the GAAP measure of Income tax expense to the non-GAAP measure of Adjusted Income Tax Expense: Six months ended January 31, Adjusted Income Before Income Taxes: Brady is presenting the non-GAAP measure, "Adjusted Income Before Income Taxes." This is not a calculation based upon GAAP. The amounts included in this non-GAAP measure are derived from amounts included in the Consolidated Financial Statements and supporting footnote disclosures. We do not view these items to be part of our ongoing results. We believe this profit measure provides an important perspective of underlying business trends and results and provides a more comparable measure from year to year. The table below provides a reconciliation of the GAAP measure of Income before income taxes to the non-GAAP measure of Adjusted Income Before Income Taxes: Adjusted Income Tax Expense: Six months ended January 31, Income tax expense (GAAP measure)
\n

\n

 
\n
\n\n
\n\n
Non-GAAP Reconciliations 18 2025 2024 2025 2024 40,334$ 43,628$ 87,117$ 90,869$ Amortization expense 3,546 1,816 7,126 3,625 Facility closure and other reorganization costs 4,241 - 4,241 - Non-recurring acquisition-related costs and other expenses - - 3,794 - 48,121$ 45,444$ 102,278$ 94,494$ 2025 2024 2025 2024 $ 0.83 $ 0.90 $ 1.81 $ 1.86 Amortization expense 0.07 0.04 0.15 0.07 Facility closure and other reorganization costs 0.09 - 0.09 - Non-recurring acquisition-related costs and other expenses - - 0.08 - 1.00$ 0.93$ 2.12$ 1.94$ Diluted EPS Excluding Certain Items Guidance: Low High Earnings per diluted Class A Common Share (GAAP measure) $ 3.99 $ 4.24 Amortization expense 0.29 0.29 Facility closure and other reorganization costs 0.09 0.09 Non-recurring acquisition-related costs and other expenses 0.08 0.08 Adjusted Diluted EPS (non-GAAP measure) 4.45$ 4.70$ GAAP to NON-GAAP MEASURES (Unaudited; Dollars in Thousands, Except Per Share Amounts) In accordance with the U.S. Securities and Exchange Commission’s Regulation G, the following provides definitions of the non-GAAP measures used in the earnings release and the reconciliation to the most closely related GAAP measure. Adjusted Diluted EPS (non-GAAP measure) Three months ended January 31, Brady is presenting the non-GAAP measure, "Adjusted Net Income." This is not a calculation based upon GAAP. The amounts included in this non-GAAP measure are derived from amounts included in the Consolidated Financial Statements and supporting footnote disclosures. We do not view these items to be part of our ongoing results. We believe this measure provides an important perspective of underlying business trends and results and provides a more comparable measure from year to year. The table below provides a reconciliation of the GAAP measure of Net income to the non-GAAP measure of Adjusted Net Income: Six months ended January 31, Net income (GAAP measure) Adjusted Net Income (non-GAAP measure) Adjusted Net Income: Fiscal 2025 Expectations Three months ended January 31, Brady is presenting the non-GAAP measure, "Adjusted Diluted EPS." This is not a calculation based upon GAAP. The amounts included in this non-GAAP measure are derived from amounts included in the Consolidated Financial Statements. We do not view these items to be part of our ongoing results. We believe this measure provides an important perspective of underlying business trends and results and provides a more comparable measure from year to year. The table below provides a reconciliation of the GAAP measure of Net income per Class A Nonvoting Common Share to the non-GAAP measure of Adjusted Diluted EPS (Note that certain amounts will not foot due to rounding): Six months ended January 31, Net income per Class A Nonvoting Common Share (GAAP measure) Adjusted Diluted EPS:
\n

\n

 
\n
\n
\n
\n\n\n","error":null}